← Consumer Healthcare Products Association
FDANonrulemakingFDA-2019-D-4447

Transdermal and Topical Delivery Systems - Product Development and Quality Considerations; Draft Guidance for Industry; Availability

RIN
—
Last modified
May 30, 2023
Comment window
closed 2351d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Mar 3, 2020 and Mar 3, 2020. 0 other organizations filed here. The comment window closed 2351d ago.

What Consumer Healthcare Products Association filed (1)

Mar 3, 2020· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2019-D-4447-0017

Please find attached comments from the Consumer Healthcare Products Association on the "Transdermal and Topical Delivery Systems - Product Development and Quality Considerations" draft guidance. Regards, Jay Sirois

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →